glp-1 hong kong ⏳ Exactly one month to go until Kong! On 27 August 2026, I will deliver the opening keynote at MedTech World Asia: The New Obesity Paradigm: Drugs, Devices, Data and Policy Wegovy (Semaglutide) GLP-1｜Begin Your Scientific

Eli Lilly's obesity pill, orforglipron, had a 12.4% average weight loss at its highest dose over 72 weeks, which means it's less effective than injections on the market

The nasal spray format was not chosen for convenience, but for its utility in modeling alternative delivery pathways - especially in metabolic or neuroendocrine research scenarios

Health care professionals who are considering working with compounders to obtain semaglutide products should be aware that compounders may be using salt forms of semaglutide

Once internalized, the receptor faces two possible fates

They are not recommended for those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Wallblom, K., Lundgren, S., Saleh, K., Schmidtchen, A